Guildford, UK, 19 April 2013: ReNeuron announces that later today it will be presenting important new pre-clinical data on the potential mechanisms by which its lead CTX stem cell line exerts its therapeutic effects.
Guildford and London, UK – 28 March 2013: ReNeuron and the Cell Therapy Catapult, which is focused on the development of the UK cell therapy industry to increase the nation’s health and wealth, are pleased to announce they have signed an agreement to work together on new cell therapy manufacturing technologies and assays. The Cell Therapy Catapult is a centre of excellence for regenerative medicine established in 2012 to stimulate innovation in this area.
Guildford, UK, 27 March 2013: ReNeuron provides an update on progress with its ReN001 stem cell therapy for disabled stroke patients.
Guildford, UK, 26 March 2013: ReNeuron is pleased to announce that it has received regulatory and ethical approvals to commence a Phase I clinical trial in the UK with its ReN009 stem cell therapy programme targeting the major unmet medical need, critical limb ischaemia (CLI).
Guildford, UK, 11 March 2013: ReNeuron is pleased to announce that it has been awarded two separate grants, totalling £1.2 million, from the UK Biomedical Catalyst to pursue further development of two of its core stem cell therapy candidates.
Guildford, UK, 29 January 2013: ReNeuron provides an update on progress with the PISCES clinical trial of its ReN001 stem cell therapy for disabled stroke patients.
Please click on link below for webcast of 2012 Interim Results presentation to analysts
Guildford, UK, 4 December 2012: ReNeuron announces its interim results for the six months ended 30 September 2012.
Guildford, UK, 4 December 2012: ReNeuron announces that it will be participating at the UK Stroke Association’s 7th UK Stroke Forum conference taking place in Harrogate on 4-6 December.
Guildford,UK, 22 November 2012: ReNeuron announces the publication, in two leading peer-reviewed scientific journals, of key non-clinical data demonstrating the multiple ways in which its lead CTX neural stem cell line promotes repair in stroke-damaged brain.
